Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
70.00
+0.93 (1.35%)
At close: Jan 16, 2026, 4:00 PM EST
68.64
-1.36 (-1.94%)
After-hours: Jan 16, 2026, 5:51 PM EST
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $467.78 million as of January 16, 2026. Its market cap has increased by 248.66% in one year.
Market Cap
467.78M
Enterprise Value
324.21M
1-Year Change
248.66%
Ranking
Category
Stock Price
$70.00
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $467.78M, an increase of 69.39%. That is a compound annual growth rate of 9.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 467.78M | 7.20% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |